Neurology Today in 5 podcast

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

0:00
4:35
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

Fler avsnitt från "Neurology Today in 5"